Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy

重新调整用途 氯喹 药物重新定位 医学 羟基氯喹 临床试验 癌症 自噬 药品 药理学 辅助治疗 佐剂 疟疾 肿瘤科 细胞凋亡 内科学 免疫学 化学 生物 疾病 2019年冠状病毒病(COVID-19) 传染病(医学专业) 生物化学 生态学
作者
Winnie Fong,Kenneth K.W. To
出处
期刊:Recent Patents on Anti-cancer Drug Discovery [Bentham Science Publishers]
卷期号:16 (2): 204-221 被引量:14
标识
DOI:10.2174/1574892815666210106111012
摘要

Background: Drug repurposing is emerging as an attractive strategy with lower attrition rate, lower cost and shorter timeframe than traditional drug discovery methods. Chloroquine (CQ) and its analogs are old drugs originally indicated for malaria treatment. Serendipitous discovery in early years revealed its anti-inflammatory properties, thus allowing its repositioned use in autoimmune diseases. Recent evidence also suggested its potential therapeutic use for anticancer therapy. Objective: This article reviews the molecular mechanisms, clinical evaluation and recent patents of CQ analogs in cancer therapy. Methods: Literature and patent searches were conducted using PubMed database and Google Patent/ USPTO Patent Search database, respectively. The keywords including “chloroquine”, “hydroxychloroquine”, “chloroquine analogs”, “chloroquine derivatives”, “repurposing”, “autophagy”, and “cancer” were used. Results: CQ analogs have been reported to elicit their anticancer effects by modulating autophagy, inducing apoptosis, eliminating cancer stem cells, normalizing tumor vasculature and modulating antitumor immunity. As documented by recent patents and clinical trials, CQ analogs have been repurposed as an adjuvant therapy and combined with other anticancer agents for synergistic enhancement of treatment efficacy. However, most clinical trials on CQ only demonstrated modest improvement in anti-cancer efficacy. Conclusion: Given that CQ loses its anticancer activity in acidic and hypoxic environment within a tumor, novel CQ analogs and/or their formulations are under active investigation to improve their physicochemical properties and biological activity. On the other hand, identification of new biomarkers for better patient selection has been advocated in future trials in order to realize the repurposing of CQ analogs for cancer treatment in a personalized manner.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhouxuefeng完成签到,获得积分10
刚刚
Akim应助爱科研采纳,获得50
1秒前
2秒前
朱建军应助科研通管家采纳,获得10
2秒前
李爱国应助科研通管家采纳,获得10
3秒前
香蕉觅云应助科研通管家采纳,获得10
3秒前
3秒前
RC_Wang应助科研通管家采纳,获得10
3秒前
3秒前
共享精神应助Volcano采纳,获得10
7秒前
7秒前
7秒前
ali完成签到,获得积分20
8秒前
han发布了新的文献求助10
9秒前
大个应助无限雨南采纳,获得10
10秒前
丘比特应助幽默尔蓝采纳,获得10
10秒前
EED发布了新的文献求助10
11秒前
11秒前
yy完成签到,获得积分10
12秒前
12秒前
12秒前
李爱国应助十三儿采纳,获得10
13秒前
ali发布了新的文献求助10
14秒前
14秒前
HOME发布了新的文献求助10
16秒前
熊大哥发布了新的文献求助10
18秒前
19秒前
科研马完成签到,获得积分10
20秒前
猫和老鼠发布了新的文献求助10
21秒前
21秒前
22秒前
发篇Sci不过分吧完成签到,获得积分20
22秒前
奥特超曼应助易槐采纳,获得10
24秒前
24秒前
上官若男应助Supreme采纳,获得10
24秒前
熊大哥完成签到,获得积分10
24秒前
24秒前
25秒前
小蘑菇应助威武的手链采纳,获得10
25秒前
可爱千兰完成签到,获得积分10
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988920
求助须知:如何正确求助?哪些是违规求助? 3531290
关于积分的说明 11253247
捐赠科研通 3269903
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882027
科研通“疑难数据库(出版商)”最低求助积分说明 809052